Summary

Proton Pump Inhibitors: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Proton Pump Inhibitors offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Drug Type:

• Esomeprazole
• Omeprazole
• Dexlansoprazole
• Pantoprazole
• Rabeprazole
• Lansoprazole
• Others

By Route of Administration:

• Oral
• Injectable

By Dosage Form:

• Tablet
• Capsules
• Injection
• Others

By Prescription:

• Branded
• Generics

By Indication:

• Gastroesophageal Reflux Disease
• Heartburn
• Peptic ulcers
• Others

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Speciality Clinics

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Report Chapters

Executive Summary

The executive summary of the Proton Pump Inhibitors includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Proton Pump Inhibitors.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Proton Pump Inhibitors in this chapter, which will help to understand basic information about Proton Pump Inhibitors. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Proton Pump Inhibitors report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Drug Type processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Proton Pump Inhibitors Demand Analysis 2018-2022 and Forecast, 2023-2033

The chapter include historical market value (USD 2.8 Billion) analysis (2018-2022) and current and future market value (USD 4.9 Billion) and volume (5.2%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Proton Pump Inhibitors - Pricing Analysis

Based on By Drug Type, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033, By Drug Type

Based on By Drug Type, Proton Pump Inhibitors is segmented into Esomeprazole, Omeprazole, Dexlansoprazole, Pantoprazole, Rabeprazole, Lansoprazole, Others. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Drug Type.

Chapter 06 - Global Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033, By Route of Administration

Based on By Route of Administration, Proton Pump Inhibitors is segmented into Oral, Injectable. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Route of Administration.

Chapter 07 - Global Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033, By Dosage Form

Based on By Dosage Form, Proton Pump Inhibitors is segmented Tablet, Capsules, Injection, Others. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Dosage Form.

Chapter 08 - Global Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033, By Prescription

Based on By Prescription, Proton Pump Inhibitors is segmented into Branded, Generics. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Prescription.

Chapter 09 - Global Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033, By Indication

Based on By Indication, Proton Pump Inhibitors is segmented into Gastroesophageal Reflux Disease, Heartburn, Peptic ulcers, Others. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Indication.



Chapter 10 - Global Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel

Based on By Distribution Channel, Proton Pump Inhibitors is segmented into Hospital Pharmacies, Retail Pharmacies, Drug Stores, Speciality Clinics. This section also offers market attractiveness analysis based on By Distribution Channel. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Distribution Channel.

Chapter 11 - Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033, By Region

Based on By Region, Proton Pump Inhibitors is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 12 - North America Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of the Proton Pump Inhibitors in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 13 - Latin America Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Proton Pump Inhibitors in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Proton Pump Inhibitors in the Latin America region.

Chapter 14 - Europe Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Proton Pump Inhibitors in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Proton Pump Inhibitors in the regional market.

Chapter 15 - East Asia Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Proton Pump Inhibitors in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Proton Pump Inhibitors in the regional market.

Chapter 16 - South Asia Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Proton Pump Inhibitors in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Proton Pump Inhibitors in the regional market.

Chapter 17 - Middle East and Africa Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Proton Pump Inhibitors in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Proton Pump Inhibitors in the regional market.

Chapter 18 - Key Countries Proton Pump Inhibitors Analysis 2018-2022 and Forecast 2023-2033

This chapter offers insights into how the Proton Pump Inhibitors is expected to grow in major countries globally.

Chapter 19 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 20 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Drug Type portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are AstraZeneca, Bayer AG, Cadila Pharmaceuticals, Eisai Inc., GlaxoSmithKline PLC, Pfizer Inc., Takeda Pharmaceuticals, Sanofi SA, Perrigo Company PLC, Dr. Reddy's Laboratories, Redhill Pharma Limited, Cipla Limited

Chapter 21 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Proton Pump Inhibitors report.

Chapter 22 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Proton Pump Inhibitors.

ページTOPに戻る

Table of Contents

1. Executive Summary
2. Market Overview
3. Key Market Trends
4. Value-Added Insights
5. Market Background
6. Global Market Demand (in Value or Size in USD Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Drug Type
7.1. Esomeprazole
7.2. Omeprazole
7.3. Dexlansoprazole
7.4. Pantoprazole
7.5. Rabeprazole
7.6. Lansoprazole
7.7. Others
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Route Administration
8.1. Oral
8.2. Injectable
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Dosage Form
9.1. Tablet
9.2. Capsules
9.3. Injection
9.4. Others
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Prescription Type
10.1. Branded
10.2. Generics
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Indication
11.1. Gastroesophageal Reflux Disease
11.2. Heartburn
11.3. Peptic ulcers
11.4. Others
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Distribution Channel
12.1. Hospital Pharmacies
12.2. Retail Pharmacies
12.3. Drug Stores
12.4. Specialty Clinics
13. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
13.1. North America
13.2. Latin America
13.3. Europe
13.4. East Asia
13.5. South Asia
13.6. Oceania
13.7. Middle East and Africa (MEA)
14. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15. Current and Future Market Size (USD Million) Analysis and Forecast By Market Taxonomy, 2023 to 2033
16. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
19. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
20. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
21. Middle East and Africa (MEA) Market Analysis 2017 to 2022 and Forecast 2023 to 2033
22. Market Structure Analysis
23. Competition Analysis
23.1. AstraZeneca
23.2. Bayer AG
23.3. Cadila Pharmaceuticals
23.4. Eisai Inc.
23.5. GlaxoSmithKline PLC
23.6. Pfizer Inc.
23.7. Takeda Pharmaceuticals
23.8. Sanofi SA
23.9. Perrigo Company PLC
23.10. Dr. Reddy's Laboratories
23.11. Redhill Pharma Limited
23.12. Cipla Limited
24. Assumptions and Acronyms Used
25. Research Methodology